Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
Phase II trial with three independent strata to independently assess the effects of the
association of pembrolizumab and cabozantinib in advanced sarcomas.